Thursday, October 18, 2018

bio technology

bio technology
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange

AbbVie Doubles Down on Cancer Project with Biotech Group Argenx

BRUSSELS (Reuters) Biotech group Argenx said on Wednesday U.S. pharma group AbbVie had exercised an exclusive option to develop and commercialize one of its...
Express Scripts Chief Medical Officer Steve Miller poses for a portrait in the Manhattan borough of New York

Express Scripts Staking Out Million-Dollar Gene Therapies

By Caroline Humer and Deena Beasley (Reuters)  Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now...
High-fiber wheat plants grow in a Calyxt greenhouse in New Brighton

Gene-Editing Startups Ignite The Next ‘Frankenfood’ Fight

By Rod Nickel (Reuters) In a suburban Minneapolis laboratory, a tiny company that has never turned a profit is poised to beat the world's biggest...
Biotech incubator taps investors through in-house brokerage

Special Report: Biotech Incubator Taps Investors through In-House Brokerage

By Elizabeth Dilts, Benjamin Lesser, Carl O'Donnell and Michael Erman NEW YORK (Reuters) Last August, National Securities Corp analyst Jonathan Aschoff was bullish on Avenue...
The last two northern white rhino females graze alongside a southern white rhino at Kenya's Laikipia National Park

Scientists Hope Test-Tube Embryos Can Save Near-Extinct White Rhino

By Kate Kelland LONDON (Reuters)  Scientists have created hybrid embryos from the sperm of near-extinct northern white rhinoceroses in the laboratory, hoping they can ultimately help...
Roche tablets positioned in front of a displayed Roche logo

Roche Pays $2.4 Billion for Rest of Cancer Expert Foundation Medicine

By Michael Shields and Ben Hirschler ZURICH/LONDON (Reuters) Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine (FMI), raising its...
- Advertisement -
banner